Xeljanz | search
Click here to view Xeljanz news from 60+ newspapers.
Bookmark or Share- HIGHLIGHTS OF PRESCRIBING INFORMATION : XELJANZ/XELJANZ Oral Solution ...Psoriatic Arthritis: XELJANZ/XELJANZ XR is indicated for the treatment of adult patients with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate or...
- Xeljanz: Uses, Side Effects, Warnings - Drugs.comXeljanz (tofacitinib) is an oral Janus kinase (JAK) inhibitor that may be used alone or with other medications to reduce inflammation associated with inflammatory and autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative
- Home Page | XELJANZ® (tofacitinib) | Safety InfoXELJANZ is a Janus kinase (JAK) inhibitor that helps regulate an overactive immune system. It helps disrupt JAK pathways from inside the cells, which are believed to play a role in inflammation. Take an active role in your treatment with tools and support resources—delivered directly to you.
- Tofacitinib - WikipediaTofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis, and ulcerative colitis.
- Home Page | XELJANZ® (tofacitinib) For RA | Safety InfoHow XELJANZ Works. XELJANZ is a Janus kinase (JAK) inhibitor that helps regulate an overactive immune system. It helps disrupt JAK pathways from inside the cells, which are believed to play a role in inflammation. XELJANZ helps reduce inflammation, a cause of permanent joint damage.
More
